Supporting Patients During GLP-1 Receptor Agonist Shortages


Updated: 12/01/23

Due to the glycemic, weight loss, and cardiovascular benefits of GLP-1 receptor agonists, many of these medications are experiencing short-term shortages. Here are some tips for supporting patients during medication shortages.
This one-page guide, developed by Jonathan Gabison, MD (first author), Lauren Oshman, MD, MPH, FAACP and Heidi Diez, PharmD, provides dosing and titration guidelines for switching between GLP-1 RA/GIPs during the national shortage in the United States, as well as functional tips for navigating medication shortages.
Patients: Please leave feedback about this tool (counts towards PO-Level VBR requirement)

Tags: For Providers, Point-of-care, Created By MCT2D

MCT2D Newsletter

Subscribe to the MCT2D Newsletter

Once per month we deliver news, updates, events, and more directly to you!